Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy.
Stefano ScaleraBiagio RicciutiDaniele MarinelliMarco MazzottaLaura CiprianiGiulia BonGiulia SchiavoniIrene TerrenatoAlessandro Di FedericoJoao M Victor AlessiMaurizio FanciulliLudovica CiuffredaFrancesca De NicolaFrauke GoemanGiulio CaravagnaDaniele SantiniRuggero De MariaFederico CappuzzoGennaro CilibertoMariam Jamal-HanjaniMark M AwadNicholas McGranahanMarcello Maugeri-SaccàPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
We identified a KEAPness phenotype across evolutionary divergent tumors. KEAPness outperforms mutation-based classifiers as a biomarker of inferior survival outcomes in NSCLC patients treated with immunotherapy.